Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

4.0K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.0K
Glucose Transporters01:27

Glucose Transporters

27.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.3K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

35.3K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
35.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

6.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.5K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A versatile bioelectronic interface programmed for hormone sensing.

Nature communications·2023
Same author

Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study.

Therapeutic advances in rare disease·2023
Same author

Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria.

Life (Basel, Switzerland)·2023
Same author

SHP-1 localization to the activating immune synapse promotes NK cell tolerance in MHC class I deficiency.

Science signaling·2023
Same author

Severe Abdominal Pain After Bariatric Surgery: Think Twice-Think Porphyria!

Obesity surgery·2023
Same author

Platelet transfusion improves clot formation and platelet function in severely thrombocytopenic haematology patients.

British journal of haematology·2021

Related Experiment Video

Updated: Jan 23, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

7.7K

Glucose Variations During Driving in People With Type 1 Diabetes Using a Continuous Glucose Monitoring System.

Laurent Silvan Schmied1, Henryk Zulewski2,3

  • 1Department of Internal Medicine, University Hospital Basel, Basel, Switzerland henryk.zulewski@unibas.ch laurent.schmied@usb.ch.

Diabetes Care
|June 22, 2019
PubMed
Summary
This summary is machine-generated.

Driving can affect blood sugar levels in people with type 1 diabetes (T1D). Real-life driving caused an initial rise in interstitial fluid glucose, followed by a decrease, unlike control conditions.

More Related Videos

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
10:35

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo

Published on: April 6, 2022

3.2K
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

5.7K

Related Experiment Videos

Last Updated: Jan 23, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

7.7K
Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
10:35

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo

Published on: April 6, 2022

3.2K
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

5.7K

Area of Science:

  • Endocrinology
  • Diabetes Management
  • Transportation Safety

Background:

  • Hypoglycemic events pose significant risks for individuals with type 1 diabetes (T1D) while driving.
  • Previous research indicated potential glucose metabolism changes during simulated driving.

Purpose of the Study:

  • To investigate interstitial fluid (ISF) glucose dynamics in individuals with T1D during real-life driving conditions.
  • To compare ISF glucose changes during driving versus non-driving control periods.

Main Methods:

  • Continuous glucose monitoring (CGM) was employed to measure ISF glucose levels.
  • Ten participants with stable T1D completed a 2-hour driving course.
  • Control conditions involved similar time periods without driving.

Main Results:

  • A notable increase in ISF glucose was observed during the initial phase of real-life driving.
  • Following the initial rise, ISF glucose levels subsequently decreased.
  • No significant ISF glucose fluctuations were recorded during control periods.

Conclusions:

  • Real-world driving appears to influence ISF glucose levels in individuals with well-controlled T1D, with an initial increase followed by a decrease.
  • These findings highlight a potential physiological response to driving that warrants further investigation.
  • The study population was specific, and results may not be generalizable to all individuals with T1D.